CreditReports.dk
HomeScreen companies

Nordisk Pharma ApS Financials, key figures and credit report

CVR number: 42852287 Established 2021 Industry: 32 Other manufacturing
Company contact details
Stenkløvervænget 21, 2625 Vallensbæk
Gross profit 365.2 kDKK FY 2025 -33.9% vs 2024
EBIT 280.5 kDKK FY 2025 -49.3% vs 2024
Net debt -1 209.5 kDKK FY 2025 -13.6% vs 2024
Quick ratio 6.0 FY 2025 +1.8 vs 2024

Income statement (kDKK)

2022
2023
2024
2025
Fiscal period length12121212
Net sales
Gross profit-18.80331.91552.86365.25
Employee benefit expenses-84.75
EBIT-18.80331.91552.86280.50
Other financial expenses-0.20-5.84-11.85
Pre-tax profit-19.00331.91547.03268.65
Income taxes-68.93- 121.51-61.42
Net earnings-19.00262.98425.52207.22

Assets (kDKK)

2022
2023
2024
2025
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Raw materials and consumables60.3842.8465.36
Inventories total60.3842.8465.36
Current trade debtors250.12200.21170.97
Current other receivables0.58
Short term receivables total0.58250.12200.21170.97
Cash and bank deposits320.44436.101 064.641 209.54
Cash and cash equivalents320.44436.101 064.641 209.54
Balance sheet total (assets)321.02746.601 307.701 445.88

Equity and liabilities (kDKK)

2022
2023
2024
2025
Share capital340.00340.00340.00340.00
Retained earnings-19.00243.98669.50
Profit of the financial year-19.00262.98425.52207.22
Shareholders equity total321.00583.981 009.501 216.73
Non-current liabilities total
Current trade creditors16.2542.0647.83
Short-term deferred tax liabilities68.93121.5153.42
Other non-interest bearing current liabilities0.0377.45134.62127.90
Current liabilities total0.03162.62298.19229.15
Balance sheet total (liabilities)321.02746.601 307.701 445.88
Page generated